Phase II study of individual 6-mercaptopurine dose increments in children with acute lymphoblastic leukemia receiving high-dose methotrexate and peg-asparaginase
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Mercaptopurine; Methotrexate; Pegaspargase
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 09 Jan 2017 Biomarkers information updated
- 02 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2010 Actual end date (May 2009) added as reported by ClinicalTrials.gov.